Part 1
Part 2
Part 3
Part 4
Part 5
Description
Clinical trials are experiments or observations done in clinical research. Such prospective biomedical or behavioral research studies on human participants are designed to answer specific questions about biomedical or behavioral interventions, including new treatments (such as novel vaccines, drugs, dietary choices, dietary supplements, and medical devices) and known interventions that warrant further study and comparison. Clinical trials generate data on safety and efficacy. They are conducted only after they have received health authority/ethics committee approval in the country where approval of the therapy is sought. These authorities are responsible for vetting the risk/benefit ratio of the trial – their approval does not mean that the therapy is 'safe' or effective, only that the trial may be conducted. The global market for Clinical Trial was estimated to be worth US$ 46670 million in 2023 and is forecast to a readjusted size of US$ 84800 million by 2030 with a CAGR of 8.8% during the forecast period 2024-2030.
Clinical Trial Market Size(US$)
M= millions and B=billions
The industry's leading producers are Parexel, PRA Health and LabCorp (Covance), which accounted for 4.94%, 7.25% and 11.81% of revenue in 2019, respectively. By region, North America has the highest share of income, at more than 39 percent.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Clinical Trial, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyse their position in the current marketplace, and make informed business decisions regarding Clinical Trial.
The Clinical Trial market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Clinical Trial market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Clinical Trial companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Market Segmentation
Report Metric
Details
Report Title
Global Clinical Trial Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Forecasted Market Size in 2030
US$ 84800 million
CAGR(2024-2030)
8.8%
Market Size Available for Years
2024-2030
Global Clinical Trial Companies Covered
Fisher Clinical Services
Myoderm
Bilcare
CliniChain
Ancillare
MESM
ERG Holding
Apex Medical Research
Parexel
PRA Health
LabCorp (Covance)
Marken
AmerisourceBergen (World Courier)
Global Clinical Trial Market, by Region
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Clinical Trial Market, Segment by Type
Instruments(Products)
Consumables
Others
Global Clinical Trial Market, Segment by Application
Procurement and Supplies
Rentals
Others
Forecast Units
USD million in value
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on.
Chapter 2: Revenue of Clinical Trial in global and regional level.
Chapter 3: Detailed analysis of Clinical Trial company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Clinical Trial revenue, gross margin, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 8: Europe by Type, by Application and by country, revenue for each segment.
Chapter 9: Asia Pacific by Type, by Application and by region, revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Middle East and Africa, by Type, by Application and by country, revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion
Table of Contents
1 Study Coverage
1.1 Clinical Trial Product Introduction
1.2 Market by Type
1.2.1 Global Clinical Trial Market Size Growth Rate by Type (2019 VS 2023 VS 2030)
1.2.2 Instruments(Products)
1.2.3 Consumables
1.2.4 Others
1.3 Market by Application
1.3.1 Global Clinical Trial Market Size Growth Rate by Application (2019 VS 2023 VS 2030)
1.3.2 Procurement and Supplies
1.3.3 Rentals
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Clinical Trial Market Size Estimates and Forecasts
2.2 Clinical Trial Market Size by Region: 2023 Versus 2030
2.2.1 Global Clinical Trial Revenue by Region: 2019-2024
2.2.2 Global Clinical Trial Revenue Forecast by Region (2025-2030)
2.2.3 Global Clinical Trial Revenue Market Share by Region (2019-2030)
3 Global Clinical Trial by Company
3.1 Global Clinical Trial Revenue by Company (2019-2024)
3.2 Global Clinical Trial Revenue Share by Company (2019-2024)
3.3 Competitive Landscape
3.3.1 Key Clinical Trial Companies around the World: Ranking by Revenue
3.3.2 Global Clinical Trial Market Concentration Ratio (CR5 and HHI) & (2019-2024)
3.3.3 Global Clinical Trial Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.4 Global Clinical Trial Companies Headquarters & Product Type
3.4.1 Clinical Trial Companies Headquarters
3.4.2 Global Clinical Trial Companies Product & Service
3.4.3 Date of International Companies Enter into Clinical Trial Market
3.5 Global Clinical Trial Mergers & Acquisitions, Expansion Plans
4 Company Profiles
4.1 Fisher Clinical Services
4.1.1 Fisher Clinical Services Company Information
4.1.2 Fisher Clinical Services Description, Business Overview
4.1.3 Fisher Clinical Services Clinical Trial Products Offered
4.1.4 Fisher Clinical Services Clinical Trial Revenue and Gross Margin (2019-2024)
4.1.5 Fisher Clinical Services Clinical Trial Revenue by Product in 2023
4.1.6 Fisher Clinical Services Clinical Trial Revenue by Application in 2023
4.1.7 Fisher Clinical Services Clinical Trial Revenue by Geographic Area in 2023
4.1.8 Fisher Clinical Services Recent Developments
4.2 Myoderm
4.2.1 Myoderm Company Information
4.2.2 Myoderm Description, Business Overview
4.2.3 Myoderm Clinical Trial Products Offered
4.2.4 Myoderm Clinical Trial Revenue and Gross Margin (2019-2024)
4.2.5 Myoderm Clinical Trial Revenue by Product in 2023
4.2.6 Myoderm Clinical Trial Revenue by Application in 2023
4.2.7 Myoderm Clinical Trial Revenue by Geographic Area in 2023
4.2.8 Myoderm Recent Developments
4.3 Bilcare
4.3.1 Bilcare Company Information
4.3.2 Bilcare Description, Business Overview
4.3.3 Bilcare Clinical Trial Products Offered
4.3.4 Bilcare Clinical Trial Revenue and Gross Margin (2019-2024)
4.3.5 Bilcare Clinical Trial Revenue by Product in 2023
4.3.6 Bilcare Clinical Trial Revenue by Application in 2023
4.3.7 Bilcare Clinical Trial Revenue by Geographic Area in 2023
4.3.8 Bilcare Recent Developments
4.4 CliniChain
4.4.1 CliniChain Company Information
4.4.2 CliniChain Description, Business Overview
4.4.3 CliniChain Clinical Trial Products Offered
4.4.4 CliniChain Clinical Trial Revenue and Gross Margin (2019-2024)
4.4.5 CliniChain Clinical Trial Revenue by Product in 2023
4.4.6 CliniChain Clinical Trial Revenue by Application in 2023
4.4.7 CliniChain Clinical Trial Revenue by Geographic Area in 2023
4.4.8 CliniChain Recent Developments
4.5 Ancillare
4.5.1 Ancillare Company Information
4.5.2 Ancillare Description, Business Overview
4.5.3 Ancillare Clinical Trial Products Offered
4.5.4 Ancillare Clinical Trial Revenue and Gross Margin (2019-2024)
4.5.5 Ancillare Clinical Trial Revenue by Product in 2023
4.5.6 Ancillare Clinical Trial Revenue by Application in 2023
4.5.7 Ancillare Clinical Trial Revenue by Geographic Area in 2023
4.5.8 Ancillare Recent Developments
4.6 MESM
4.6.1 MESM Company Information
4.6.2 MESM Description, Business Overview
4.6.3 MESM Clinical Trial Products Offered
4.6.4 MESM Clinical Trial Revenue and Gross Margin (2019-2024)
4.6.5 MESM Clinical Trial Revenue by Product in 2023
4.6.6 MESM Clinical Trial Revenue by Application in 2023
4.6.7 MESM Clinical Trial Revenue by Geographic Area in 2023
4.6.8 MESM Recent Development
4.7 ERG Holding
4.7.1 ERG Holding Company Information
4.7.2 ERG Holding Description, Business Overview
4.7.3 ERG Holding Clinical Trial Products Offered
4.7.4 ERG Holding Clinical Trial Revenue and Gross Margin (2019-2024)
4.7.5 ERG Holding Clinical Trial Revenue by Product in 2023
4.7.6 ERG Holding Clinical Trial Revenue by Application in 2023
4.7.7 ERG Holding Clinical Trial Revenue by Geographic Area in 2023
4.7.8 ERG Holding Recent Development
4.8 Apex Medical Research
4.8.1 Apex Medical Research Company Information
4.8.2 Apex Medical Research Description, Business Overview
4.8.3 Apex Medical Research Clinical Trial Products Offered
4.8.4 Apex Medical Research Clinical Trial Revenue and Gross Margin (2019-2024)
4.8.5 Apex Medical Research Clinical Trial Revenue by Product in 2023
4.8.6 Apex Medical Research Clinical Trial Revenue by Application in 2023
4.8.7 Apex Medical Research Clinical Trial Revenue by Geographic Area in 2023
4.8.8 Apex Medical Research Recent Development
4.9 Parexel
4.9.1 Parexel Company Information
4.9.2 Parexel Description, Business Overview
4.9.3 Parexel Clinical Trial Products Offered
4.9.4 Parexel Clinical Trial Revenue and Gross Margin (2019-2024)
4.9.5 Parexel Clinical Trial Revenue by Product in 2023
4.9.6 Parexel Clinical Trial Revenue by Application in 2023
4.9.7 Parexel Clinical Trial Revenue by Geographic Area in 2023
4.9.8 Parexel Recent Development
4.10 PRA Health
4.10.1 PRA Health Company Information
4.10.2 PRA Health Description, Business Overview
4.10.3 PRA Health Clinical Trial Products Offered
4.10.4 PRA Health Clinical Trial Revenue and Gross Margin (2019-2024)
4.10.5 PRA Health Clinical Trial Revenue by Product in 2023
4.10.6 PRA Health Clinical Trial Revenue by Application in 2023
4.10.7 PRA Health Clinical Trial Revenue by Geographic Area in 2023
4.10.8 PRA Health Recent Development
4.11 LabCorp (Covance)
4.11.1 LabCorp (Covance) Company Information
4.11.2 LabCorp (Covance) Description, Business Overview
4.11.3 LabCorp (Covance) Clinical Trial Products Offered
4.11.4 LabCorp (Covance) Clinical Trial Revenue and Gross Margin (2019-2024)
4.11.5 LabCorp (Covance) Clinical Trial Revenue by Product in 2023
4.11.6 LabCorp (Covance) Clinical Trial Revenue by Application in 2023
4.11.7 LabCorp (Covance) Clinical Trial Revenue by Geographic Area in 2023
4.11.8 LabCorp (Covance) Recent Development
4.12 Marken
4.12.1 Marken Company Information
4.12.2 Marken Description, Business Overview
4.12.3 Marken Clinical Trial Products Offered
4.12.4 Marken Clinical Trial Revenue and Gross Margin (2019-2024)
4.12.5 Marken Clinical Trial Revenue by Product in 2023
4.12.6 Marken Clinical Trial Revenue by Application in 2023
4.12.7 Marken Clinical Trial Revenue by Geographic Area in 2023
4.12.8 Marken Recent Development
4.13 AmerisourceBergen (World Courier)
4.13.1 AmerisourceBergen (World Courier) Company Information
4.13.2 AmerisourceBergen (World Courier) Description, Business Overview
4.13.3 AmerisourceBergen (World Courier) Clinical Trial Products Offered
4.13.4 AmerisourceBergen (World Courier) Clinical Trial Revenue and Gross Margin (2019-2024)
4.13.5 AmerisourceBergen (World Courier) Clinical Trial Revenue by Product in 2023
4.13.6 AmerisourceBergen (World Courier) Clinical Trial Revenue by Application in 2023
4.13.7 AmerisourceBergen (World Courier) Clinical Trial Revenue by Geographic Area in 2023
4.13.8 AmerisourceBergen (World Courier) Recent Development
5 Breakdown Data by Type
5.1 Global Clinical Trial Revenue by Type (2019-2024)
5.2 Global Clinical Trial Revenue Forecast by Type (2025-2030)
5.3 Clinical Trial Revenue Market Share by Type (2019-2030)
6 Breakdown Data by Application
6.1 Global Clinical Trial Revenue by Application (2019-2024)
6.2 Global Clinical Trial Revenue Forecast by Application (2025-2030)
6.3 Clinical Trial Revenue Market Share by Application (2019-2030)
7 North America
7.1 North America Clinical Trial Market Size YoY Growth 2019-2030
7.2 North America Clinical Trial Market Facts & Figures by Country (2019-2030)
7.3 North America Clinical Trial Revenue by Type (2019-2024)
7.4 North America Clinical Trial Revenue by Application (2019-2024)
8 Asia-Pacific
8.1 Asia-Pacific Clinical Trial Market Size YoY Growth 2019-2030
8.2 Asia-Pacific Clinical Trial Market Facts & Figures by Region (2019-2030)
8.3 Asia-Pacific Clinical Trial Revenue by Type (2019-2024)
8.4 Asia-Pacific Clinical Trial Revenue by Application (2019-2024)
9 Europe
9.1 Europe Clinical Trial Market Size YoY Growth 2019-2030
9.2 Europe Clinical Trial Market Facts & Figures by Country (2019-2030)
9.3 Europe Clinical Trial Revenue by Type (2019-2024)
9.4 Europe Clinical Trial Revenue by Application (2019-2024)
10 Latin America
10.1 Latin America Clinical Trial Market Size YoY Growth 2019-2030
10.2 Latin America Clinical Trial Market Facts & Figures by Country (2019-2030)
10.3 Latin America Clinical Trial Revenue by Type (2019-2024)
10.4 Latin America Clinical Trial Revenue by Application (2019-2024)
11 Middle East and Africa
11.1 Middle East and Africa Clinical Trial Market Size YoY Growth 2019-2030
11.2 Middle East and Africa Clinical Trial Market Facts & Figures by Country (2019-2030)
11.3 Middle East and Africa Clinical Trial Revenue by Type (2019-2024)
11.4 Middle East and Africa Clinical Trial Revenue by Application (2019-2024)
12 Supply Chain and Sales Channel Analysis
12.1 Clinical Trial Supply Chain Analysis
12.2 Clinical Trial Key Raw Materials and Upstream Suppliers
12.3 Clinical Trial Clients Analysis
12.4 Clinical Trial Sales Channel and Sales Model Analysis
12.4.1 Clinical Trial Distribution Channel Analysis: Indirect Sales VS Direct Sales
12.4.2 Clinical Trial Distribution Channel Analysis: Online Sales VS Offline Sales
12.4.3 Clinical Trial Distributors
13 Market Dynamics
13.1 Clinical Trial Industry Trends
13.2 Clinical Trial Market Drivers
13.3 Clinical Trial Market Challenges
13.4 Clinical Trial Market Restraints
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
Table of Figures
List of Tables
Table 1. Global Clinical Trial Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Major Companies of Instruments(Products)
Table 3. Major Companies of Consumables
Table 4. Major Companies of Others
Table 5. Global Clinical Trial Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Clinical Trial Market Size by Region (US$ Million): 2023 VS 2030
Table 7. Global Clinical Trial Revenue by Region (2019-2024) & (US$ Million)
Table 8. Global Clinical Trial Revenue Forecast by Region (2025-2030) & (US$ Million)
Table 9. Clinical Trial Revenue by Company (2019-2024) & (US$ Million)
Table 10. Clinical Trial Revenue Share by Company (2019-2024)
Table 11. Ranking of Global Top Clinical Trial Players by Revenue (US$ Million) in 2023
Table 12. Global Clinical Trial Companies Market Concentration Ratio (CR5 and HHI) & (2019-2024)
Table 13. Global Clinical Trial by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Clinical Trial as of 2023)
Table 14. Global Clinical Trial Companies Headquarters
Table 15. Global Clinical Trial Companies Product & Service
Table 16. Date of International Companies Enter into Clinical Trial Market
Table 17. Global Clinical Trial Mergers & Acquisitions, Expansion Plans
Table 18. Fisher Clinical Services Company Information
Table 19. Fisher Clinical Services Description and Business Overview
Table 20. Fisher Clinical Services Clinical Trial Product
Table 21. Fisher Clinical Services Clinical Trial Revenue (US$ Million) and Gross Margin (2019-2024)
Table 22. Fisher Clinical Services Revenue Proportion of Clinical Trial by Product in 2023
Table 23. Fisher Clinical Services Revenue Proportion of Clinical Trial by Application in 2023
Table 24. Fisher Clinical Services Revenue Proportion of Clinical Trial by Geographic Area in 2023
Table 25. Fisher Clinical Services Recent Development
Table 26. Myoderm Company Information
Table 27. Myoderm Description and Business Overview
Table 28. Myoderm Clinical Trial Product
Table 29. Myoderm Clinical Trial Revenue (US$ Million) and Gross Margin (2019-2024)
Table 30. Myoderm Revenue Proportion of Clinical Trial by Product in 2023
Table 31. Myoderm Revenue Proportion of Clinical Trial by Application in 2023
Table 32. Myoderm Revenue Proportion of Clinical Trial by Geographic Area in 2023
Table 33. Myoderm Recent Development
Table 34. Bilcare Company Information
Table 35. Bilcare Description and Business Overview
Table 36. Bilcare Clinical Trial Product
Table 37. Bilcare Clinical Trial Revenue (US$ Million) and Gross Margin (2019-2024)
Table 38. Bilcare Revenue Proportion of Clinical Trial by Product in 2023
Table 39. Bilcare Revenue Proportion of Clinical Trial by Application in 2023
Table 40. Bilcare Revenue Proportion of Clinical Trial by Geographic Area in 2023
Table 41. Bilcare Recent Development
Table 42. CliniChain Company Information
Table 43. CliniChain Description and Business Overview
Table 44. CliniChain Clinical Trial Product
Table 45. CliniChain Clinical Trial Revenue (US$ Million) and Gross Margin (2019-2024)
Table 46. CliniChain Revenue Proportion of Clinical Trial by Product in 2023
Table 47. CliniChain Revenue Proportion of Clinical Trial by Application in 2023
Table 48. CliniChain Revenue Proportion of Clinical Trial by Geographic Area in 2023
Table 49. CliniChain Recent Development
Table 50. Ancillare Company Information
Table 51. Ancillare Description and Business Overview
Table 52. Ancillare Clinical Trial Product
Table 53. Ancillare Clinical Trial Revenue (US$ Million) and Gross Margin (2019-2024)
Table 54. Ancillare Revenue Proportion of Clinical Trial by Product in 2023
Table 55. Ancillare Revenue Proportion of Clinical Trial by Application in 2023
Table 56. Ancillare Revenue Proportion of Clinical Trial by Geographic Area in 2023
Table 57. Ancillare Recent Development
Table 58. MESM Company Information
Table 59. MESM Description and Business Overview
Table 60. MESM Clinical Trial Product
Table 61. MESM Clinical Trial Revenue (US$ Million) and Gross Margin (2019-2024)
Table 62. MESM Revenue Proportion of Clinical Trial by Product in 2023
Table 63. MESM Revenue Proportion of Clinical Trial by Application in 2023
Table 64. MESM Revenue Proportion of Clinical Trial by Geographic Area in 2023
Table 65. MESM Recent Development
Table 66. ERG Holding Company Information
Table 67. ERG Holding Description and Business Overview
Table 68. ERG Holding Clinical Trial Product
Table 69. ERG Holding Clinical Trial Revenue (US$ Million) and Gross Margin (2019-2024)
Table 70. ERG Holding Revenue Proportion of Clinical Trial by Product in 2023
Table 71. ERG Holding Revenue Proportion of Clinical Trial by Application in 2023
Table 72. ERG Holding Revenue Proportion of Clinical Trial by Geographic Area in 2023
Table 73. ERG Holding Recent Development
Table 74. Apex Medical Research Company Information
Table 75. Apex Medical Research Description and Business Overview
Table 76. Apex Medical Research Clinical Trial Product
Table 77. Apex Medical Research Clinical Trial Revenue (US$ Million) and Gross Margin (2019-2024)
Table 78. Apex Medical Research Revenue Proportion of Clinical Trial by Product in 2023
Table 79. Apex Medical Research Revenue Proportion of Clinical Trial by Application in 2023
Table 80. Apex Medical Research Revenue Proportion of Clinical Trial by Geographic Area in 2023
Table 81. Apex Medical Research Recent Development
Table 82. Parexel Company Information
Table 83. Parexel Description and Business Overview
Table 84. Parexel Clinical Trial Product
Table 85. Parexel Clinical Trial Revenue (US$ Million) and Gross Margin (2019-2024)
Table 86. Parexel Revenue Proportion of Clinical Trial by Product in 2023
Table 87. Parexel Revenue Proportion of Clinical Trial by Application in 2023
Table 88. Parexel Revenue Proportion of Clinical Trial by Geographic Area in 2023
Table 89. Parexel Recent Development
Table 90. PRA Health Company Information
Table 91. PRA Health Description and Business Overview
Table 92. PRA Health Clinical Trial Product
Table 93. PRA Health Clinical Trial Revenue (US$ Million) and Gross Margin (2019-2024)
Table 94. PRA Health Revenue Proportion of Clinical Trial by Product in 2023
Table 95. PRA Health Revenue Proportion of Clinical Trial by Application in 2023
Table 96. PRA Health Revenue Proportion of Clinical Trial by Geographic Area in 2023
Table 97. PRA Health Recent Development
Table 98. LabCorp (Covance) Company Information
Table 99. LabCorp (Covance) Description and Business Overview
Table 100. LabCorp (Covance) Clinical Trial Product
Table 101. LabCorp (Covance) Clinical Trial Revenue (US$ Million) and Gross Margin (2019-2024)
Table 102. LabCorp (Covance) Revenue Proportion of Clinical Trial by Product in 2023
Table 103. LabCorp (Covance) Revenue Proportion of Clinical Trial by Application in 2023
Table 104. LabCorp (Covance) Revenue Proportion of Clinical Trial by Geographic Area in 2023
Table 105. LabCorp (Covance) Recent Development
Table 106. Marken Company Information
Table 107. Marken Description and Business Overview
Table 108. Marken Clinical Trial Product
Table 109. Marken Clinical Trial Revenue (US$ Million) and Gross Margin (2019-2024)
Table 110. Marken Revenue Proportion of Clinical Trial by Product in 2023
Table 111. Marken Revenue Proportion of Clinical Trial by Application in 2023
Table 112. Marken Revenue Proportion of Clinical Trial by Geographic Area in 2023
Table 113. Marken Recent Development
Table 114. AmerisourceBergen (World Courier) Company Information
Table 115. AmerisourceBergen (World Courier) Description and Business Overview
Table 116. AmerisourceBergen (World Courier) Clinical Trial Product
Table 117. AmerisourceBergen (World Courier) Clinical Trial Revenue (US$ Million) and Gross Margin (2019-2024)
Table 118. AmerisourceBergen (World Courier) Revenue Proportion of Clinical Trial by Product in 2023
Table 119. AmerisourceBergen (World Courier) Revenue Proportion of Clinical Trial by Application in 2023
Table 120. AmerisourceBergen (World Courier) Revenue Proportion of Clinical Trial by Geographic Area in 2023
Table 121. AmerisourceBergen (World Courier) Recent Development
Table 122. Global Clinical Trial Revenue by Type (2019-2024) & (US$ Million)
Table 123. Global Clinical Trial Revenue Forecast by Type (2025-2030) & (US$ Million)
Table 124. Global Clinical Trial Revenue by Application (2019-2024) & (US$ Million)
Table 125. Global Clinical Trial Revenue Forecast by Application (2025-2030) & (US$ Million)
Table 126. North America Clinical Trial Revenue by Country (2019-2024) & (US$ Million)
Table 127. North America Clinical Trial Revenue by Country (2025-2030) & (US$ Million)
Table 128. North America Clinical Trial Revenue by Type (2019-2024) & (US$ Million)
Table 129. North America Clinical Trial Revenue by Application (2019-2024) & (US$ Million)
Table 130. Asia-Pacific Clinical Trial Revenue by Region (2019-2030) & (US$ Million)
Table 131. Asia-Pacific Clinical Trial Revenue by Region (2025-2030) & (US$ Million)
Table 132. Asia-Pacific Clinical Trial Revenue by Type (2019-2024) & (US$ Million)
Table 133. Asia-Pacific Clinical Trial Revenue by Application (2019-2024) & (US$ Million)
Table 134. Europe Clinical Trial Revenue by Country (2019-2024) & (US$ Million)
Table 135. Europe Clinical Trial Revenue by Country (2025-2030) & (US$ Million)
Table 136. Europe Clinical Trial Revenue by Type (2019-2024) & (US$ Million)
Table 137. Europe Clinical Trial Revenue by Application (2019-2024) & (US$ Million)
Table 138. Latin America Clinical Trial Revenue by Country (2019-2024) & (US$ Million)
Table 139. Latin America Clinical Trial Revenue by Country (2025-2030) & (US$ Million)
Table 140. Latin America Clinical Trial Revenue by Type (2019-2024) & (US$ Million)
Table 141. Latin America Clinical Trial Revenue by Application (2019-2024) & (US$ Million)
Table 142. Middle East and Africa Clinical Trial Revenue by Country (2019-2024) & (US$ Million)
Table 143. Middle East and Africa Clinical Trial Revenue by Country (2025-2030) & (US$ Million)
Table 144. Middle East and Africa Clinical Trial Revenue by Type (2019-2024) & (US$ Million)
Table 145. Middle East and Africa Clinical Trial Revenue by Application (2019-2024) & (US$ Million)
Table 146. Clinical Trial Key Raw Materials, Industry Status and Trend
Table 147. Clinical Trial Key Raw Materials and Upstream Suppliers
Table 148. Clinical Trial Clients Status and Trend
Table 149. Clinical Trial Typical Clients
Table 150. Clinical Trial Distributors
Table 151. Clinical Trial Market Trends
Table 152. Clinical Trial Market Drivers
Table 153. Clinical Trial Market Challenges
Table 154. Clinical Trial Market Restraints
Table 155. Research Programs/Design for This Report
Table 156. Key Data Information from Secondary Sources
Table 157. Key Data Information from Primary Sources
List of Figures
Figure 1. Clinical Trial Product Picture
Figure 2. Global Clinical Trial Revenue Market Share by Type in 2023 & 2030
Figure 3. Instruments(Products) Product Picture
Figure 4. Consumables Product Picture
Figure 5. Others Product Picture
Figure 6. Global Clinical Trial Revenue Market Share by Application in 2023 & 2030
Figure 7. Procurement and Supplies
Figure 8. Rentals
Figure 9. Others
Figure 10. Clinical Trial Report Years Considered
Figure 11. Global Clinical Trial Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Clinical Trial Market Size 2019-2030 (US$ Million)
Figure 13. Global Clinical Trial Market Size Market Share by Region: 2023 Versus 2030
Figure 14. Global Clinical Trial Revenue Market Share by Region (2019-2030)
Figure 15. Clinical Trial Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 16. Global Clinical Trial Revenue Market Share Forecast by Type (2019-2030)
Figure 17. Global Clinical Trial Revenue Market Share Forecast by Application (2019-2030)
Figure 18. North America Clinical Trial Revenue 2019-2030 (US$ Million)
Figure 19. North America Clinical Trial Revenue Market Share by Type (2019-2024)
Figure 20. North America Clinical Trial Revenue Market Share by Application (2019-2024)
Figure 21. Asia-Pacific Clinical Trial Revenue 2019-2030 (US$ Million)
Figure 22. Asia-Pacific Clinical Trial Revenue Market Share by Region (2019-2030)
Figure 23. Asia-Pacific Clinical Trial Revenue Market Share by Type (2019-2024)
Figure 24. Asia-Pacific Clinical Trial Revenue Market Share by Application (2019-2024)
Figure 25. Europe Clinical Trial Revenue Growth Rate 2019-2030 (US$ Million)
Figure 26. Europe Clinical Trial Revenue Market Share by Country (2019-2030)
Figure 27. Europe Clinical Trial Revenue Market Share by Type (2019-2024)
Figure 28. Europe Clinical Trial Revenue Market Share by Application (2019-2024)
Figure 29. Latin America Clinical Trial Revenue Growth Rate 2019-2030 (US$ Million)
Figure 30. Latin America Clinical Trial Revenue Market Share by Country (2019-2024)
Figure 31. Latin America Clinical Trial Revenue Market Share by Type (2019-2024)
Figure 32. Latin America Clinical Trial Revenue Market Share by Application (2019-2024)
Figure 33. Middle East and Africa Clinical Trial Revenue Growth Rate 2019-2030 (US$ Million)
Figure 34. Middle East and Africa Clinical Trial Revenue Market Share by Country (2019-2030)
Figure 35. Middle East and Africa Clinical Trial Revenue Market Share by Type (2019-2024)
Figure 36. Middle East and Africa Clinical Trial Revenue Market Share by Application (2019-2024)
Figure 37. Clinical Trial Supply Chain (Upstream and Downstream Market)
Figure 38. Global Production Market Share of Clinical Trial Raw Materials by Region in 2023
Figure 39. Clinical Trial Distribution Channels
Figure 40. Global Clinical Trial Percentage 2019-2030: Indirect Sales VS Direct Sales
Figure 41. Global Clinical Trial Percentage 2019-2030: Online Sales VS Offline Sales
Figure 42. Bottom-up and Top-down Approaches for This Report
Figure 43. Data Triangulation
Figure 44. Key Executives Interviewed
Figure 45. Global Clinical Trial Percentage 2019-2030: Online Sales VS Offline Sales
Figure 46. Bottom-up and Top-down Approaches for This Report
Figure 47. Data Triangulation
Figure 48. Key Executives Interviewed
Description
Clinical trials are experiments or observations done in clinical research. Such prospective biomedical or behavioral research studies on human participants are designed to answer specific questions about biomedical or behavioral interventions, including new treatments (such as novel vaccines, drugs, dietary choices, dietary supplements, and medical devices) and known interventions that warrant further study and comparison. Clinical trials generate data on safety and efficacy. They are conducted only after they have received health authority/ethics committee approval in the country where approval of the therapy is sought. These authorities are responsible for vetting the risk/benefit ratio of the trial – their approval does not mean that the therapy is 'safe' or effective, only that the trial may be conducted. The global market for Clinical Trial was estimated to be worth US$ 46670 million in 2023 and is forecast to a readjusted size of US$ 84800 million by 2030 with a CAGR of 8.8% during the forecast period 2024-2030.
The industry's leading producers are Parexel, PRA Health and LabCorp (Covance), which accounted for 4.94%, 7.25% and 11.81% of revenue in 2019, respectively. By region, North America has the highest share of income, at more than 39 percent.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Clinical Trial, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyse their position in the current marketplace, and make informed business decisions regarding Clinical Trial.
The Clinical Trial market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Clinical Trial market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Clinical Trial companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Market Segmentation
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on.
Chapter 2: Revenue of Clinical Trial in global and regional level.
Chapter 3: Detailed analysis of Clinical Trial company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Clinical Trial revenue, gross margin, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 8: Europe by Type, by Application and by country, revenue for each segment.
Chapter 9: Asia Pacific by Type, by Application and by region, revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Middle East and Africa, by Type, by Application and by country, revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion
Related Reports
Clinical trials are experiments or observations done in clinical research. Such prospective biomedic
Published: 2023-05-30
Pages: 110
USD 5600.00
(Single User License)
Clinical trials are experiments or observations done in clinical research. Such prospective biomedic
Published: 2023-06-10
Pages: 91
USD 2900.00
(Single User License)
Clinical trials are experiments or observations done in clinical research. Such prospective biomedic
Published: 2023-11-03
Pages: 100
USD 3350.00
(Single User License)
Clinical trials are experiments or observations done in clinical research. Such prospective biomedic
Published: 2024-01-02
Pages: 87
USD 2900.00
(Single User License)
Clinical trials are experiments or observations done in clinical research. Such prospective biomedic
Published: 2024-01-06
Pages: 114
USD 3950.00
(Single User License)
Clinical trials are experiments or observations done in clinical research. Such prospective biomedic
Published: 2024-04-17
Pages: 145
USD 5600.00
(Single User License)
Clinical trials are experiments or observations done in clinical research. Such prospective biomedic
Published: 2024-04-07
Pages: 110
USD 4900.00
(Single User License)
The global market for Clinical Trial was valued at US$ 55180 million in the year 2024 and is project
Published: 2025-01-18
Pages: 89
USD 2900.00
(Single User License)
The global market for Clinical Trial was estimated to be worth US$ 55180 million in 2024 and is fore
Published: 2025-01-18
Pages: 102
USD 3950.00
(Single User License)
In 2024, the global market size of Clinical Trial was estimated to be worth US$ 55180 million and is
Published: 2025-03-28
Pages: 140
USD 5900.00
(Single User License)
USD 5900.00
USD 8850.00
USD 11800.00
Add to Cart
Buy Now
English
SIMON LEE
English
HITESH
Japanese
TANG XIN
Korean
SUNG-BIN YOON
English
Chinese
DAMON
Competition
Key players, new entrants,acquisitions, mergers and expansions,development trends and challenges.
Industry Analysis
Rawmaterial, application, product type, demand,supply,downstream, supply chain etc.
Market Size
Capacity, production, sales, revenue, price, cost etc.
Customized Information
We can offer customized survey and information to meet ourclient's need.
Fastest report delivery service
More than 18 years of vast experience
Operation for 24 * 7 & 365 days
In-depth and comprehensive analysis
Professional and timely after-sales service
Owns large database
Add to Cart
Buy Now